DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Dani Saurymper - 1 Saurymper - 1 CNBC's - 1 EXAS - 1 Kyle Mikson - 1 Canaccord Genuity - 1 CNBC's Arabile - 1 it's - 1
Top related locs:
Top related orgs:
Sciences - 1 Nasdaq - 1 Companies - 1 FDA - 1

Search resuls for: "Kyle Mikson"


2 mentions found


☆ This U.S. biotech stock is up 90% this year and will continue to soar, fund manager says
  + stars: | 2023-06-23 | by ( Ganesh Rao | ) www.cnbc.com   time to read: +3 min
Shares of U.S. biotech firm Exact Sciences have surged by almost 90% this year. But the run may not be over just yet, according to fund manager Dani Saurymper. Earlier this week it said its next-generation screening test, Cologuard 2.0, showed a 30% lower false positive rate for detecting the disease in a study compared to its already approved test. This is where Exact Sciences fits in. Saurymper believes that the stock has corrected and has a significant runway ahead.
Persons: Dani Saurymper, Saurymper, CNBC's, EXAS, Kyle Mikson, Canaccord Genuity, CNBC's Arabile, it's Organizations: Sciences, Nasdaq, Companies, FDA
☆ This little-known health stock that uses A.I. can rally more than 120%, Canaccord Genuity says
  + stars: | 2023-02-22 | by ( Pia Singh | ) www.cnbc.com   time to read: +2 min
Oncology stock Guardant Health could be a big winner in the ChatGPT-driven artificial intelligence frenzy, according to Canaccord Genuity. Canaccord anticipates Guardant Health will see some upside, boosted by its AI-related suite of technology the company announced in January . ChatGPT also could enable 24-hour/7-day access to healthcare services," Mikson wrote. Guardant Health last month announced the launch of its Guardant Galaxy platform, which includes technologies that will aid in the company's tests and enable biomarker and drug discovery. The first application in the company's product suite is an AI-backed digital-pathology platform developed by Lunit, a South Korea-based company.
0 next >>
Total: 2